Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 561 – 580 of 3236

Doravirina / Islatravir

https://clinicalinfo.hiv.gov/drugs/doravirine-islatravir/patient

Doravirine / Islatravir

https://clinicalinfo.hiv.gov/drugs/doravirine-islatravir/fda-labels

Update on Statin Therapy as Primary Prevention of Atherosclerotic Cardiovascular Disease in People With HIV

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/statin-therapy-people-hiv

Update to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV

https://clinicalinfo.hiv.gov/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-9

Actualizaciones a las Guías para la Prevención y Tratamiento de Infecciones Oportunistas en Adultos y Adolescentes con VIH

https://clinicalinfo.hiv.gov/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-9

The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents With HIV Announces Changes to Statin Therapy Guidance

https://clinicalinfo.hiv.gov/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-announces-changes-statin

El Panel del Departamento de Salud y Servicios Humanos sobre guías de tratamiento antirretroviral para adultos y adolescentes con VIH anuncia cambios en las recomendaciones sobre la terapia con estatinas

https://clinicalinfo.hiv.gov/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-announces-changes-statin

Update to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

https://clinicalinfo.hiv.gov/news/update-guidelines-use-antiretroviral-agents-pediatric-hiv-infection-2

Actualizaciones a las Guías para el uso de agentes antirretrovirales en la infección pediátrica por VIH

https://clinicalinfo.hiv.gov/news/update-guidelines-use-antiretroviral-agents-pediatric-hiv-infection-2

What to Start: Antiretroviral Treatment Regimens Recommended for Initial Therapy in Infants and Children With HIV

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/regimens-recommended-initial-therapy-antiretroviral-naive-children

https://clinicalinfo.hiv.gov/drugs/vh4524184/health-professional

https://clinicalinfo.hiv.gov/drugs/vh4524184/patient

https://clinicalinfo.hiv.gov/drugs/vh4524184/patient

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-archive

Scientific/Clinical Member Nominations are Now Being Accepted for the Department of Health and Human Services (HHS) Panel on Antiretroviral Therapy and Medical Management of Children Living With HIV

https://clinicalinfo.hiv.gov/news/scientificclinical-member-nominations-are-now-being-accepted-department-health-and-human-1

Se están aceptando nominaciones de miembros científicos/clínicos para el Panel del Departamento de Salud y Servicios Humanos (HHS) sobre terapia antirretroviral y manejo médico de niños que viven con VIH

https://clinicalinfo.hiv.gov/news/scientificclinical-member-nominations-are-now-being-accepted-department-health-and-human-1

https://clinicalinfo.hiv.gov/resources

https://clinicalinfo.hiv.gov/resources

Freedom of Information Act (FOIA)

https://clinicalinfo.hiv.gov/freedom-information-act-foia

Ley de Acceso a Información (FOIA, por sus siglas en inglés)

https://clinicalinfo.hiv.gov/freedom-information-act-foia